Brought to you by 
Deciphera goes public, nets $129mm through IPO
08 Jun 2018
Executive Summary
Deciphera Pharmaceuticals Inc. (developing small-molecule cancer therapies) netted $129mm through its initial public offering of 8.17mm common shares (including partial exercise of the overallotment) at $17. The company had originally hoped to sell 6.25mm common shares for between $15-17 apiece when it filed earlier this month.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Deciphera goes public, nets $129mm through IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice